LONDON: OXB (LSE: OXB), a leading global cell and gene therapy contract development and manufacturing organization (CDMO), has acquired the remaining 10% stake in its U.S. subsidiary, OXB US LLC, from Q32 Bio, Inc., securing full ownership of the facility. The move, finalized after OXB’s U.S. subsidiary exercised a prearranged call option in March, solidifies…
LONDON: Haydale (AIM: HAYD), an advanced materials group, announced that it has filed for insolvency for its wholly owned subsidiary, Haydale Ceramic Technologies LLC (HCT), in the state of Georgia. This action is part of the Group’s restructuring efforts following a business review concluded on December 23, 2024. The Group plans to sell HCT’s assets…
MELBOURNE: Visage Imaging Inc., U.S. subsidiary of Pro Medicus Limited [PME], has signed a multi-year Research Collaboration agreement with NYU Langone Health, one of the most highly regarded health systems in North America. Under the terms of the agreement, the two parties will work together to design and develop next-generation products for enterprise imaging in…